Methoxphenidine
Standing risks
| Risk | Recorded values | Confidence | Article section |
|---|---|---|---|
| High overdose risk, use caution |
| medium | View in article: High overdose risk, use caution |
Lethal interactions
| Combination | Type | Severity | Mechanisms | Confidence |
|---|---|---|---|---|
| GHB, GBL | Drug class | lethal | 2 | medium |
Dangerous interactions
30 dangerous interactions recorded for this substance.
See the full interactions tableContraindications
| Condition | Severity | Note |
|---|---|---|
| Cardiovascular | ||
| hypertension | absolute | MXP consistently produces significant cardiovascular stress including hypertension and tachycardia. Individuals with uncontrolled hypertension, coronary artery disease, heart failure, or arrhythmias face substantially elevated risk of cardiovascular emergency. |
| coronary artery disease | absolute | The consistent cardiovascular stress profile of MXP intoxication poses particular danger to individuals with coronary artery disease or other structural heart conditions. |
| Neurological | ||
| epilepsy | absolute | Seizures have been reported in MXP intoxication cases. Individuals with epilepsy or conditions that lower seizure threshold face elevated risk. |
| Psychiatric | ||
| psychotic disorders | absolute | MXP produces hallucinations, confusion, and psychotic symptoms in clinical intoxications. NMDA antagonists as a class exacerbate or precipitate psychotic episodes in individuals with psychotic spectrum disorders. |
| Hepatic | ||
| hepatic impairment | relative | Reduced hepatic metabolism could prolong and intensify MXP effects. Individuals with significant liver disease should be considered at increased risk. |
| Pregnancy & Breastfeeding | ||
| pregnancy | absolute | No reproductive or teratogenic data exist for MXP. Given its high CNS penetration and the critical role of NMDA receptor signaling in fetal brain development, use during pregnancy and breastfeeding is contraindicated by precautionary principle. |